What is Opus Genetics's price / book?

Opus Genetics (IRD) reported price / book of 9× in Q4 2025.

How has Opus Genetics's price / book changed year-over-year?

Opus Genetics's price / book increased by 61.7% year-over-year, from 5.6× to 9×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Opus Genetics IRD Price / book

Price / book at other companies

AbbVieABBV

261×+221×

MeiraGTx Holdings plcMGTX

174.8×+171×

4D Molecular TherapeuticsFDMT

1.1×+0.7×

Opko HealthOPK

0.7×-0.1×

Kodiak Sciences IncKOD

20.8×+19.4×

Regeneron PharmaceuticalsREGN

2.6×+0.2×

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Calculated from Opus Genetics’s reported figures.

market cap/total stockholders equity=9×

Based on the most recent quarter.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's price / book?: Opus Genetics (IRD) reported price / book of 9× in Q4 2025.
How has Opus Genetics's price / book changed year-over-year?: Opus Genetics's price / book increased by 61.7% year-over-year, from 5.6× to 9×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.